Latest Singulair news
FDA: Montelukast Tablet Bottles Recalled
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.
Montelukast Associated With Nightmares, Depression
posted September 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Montelukast appears to be linked to neuropsychiatric side effects, such as depression, aggression, nightmares, and headaches, according to a review published online Sept. 20 in Pharmacology Research and Perspectives.
Risk for Psychiatric Disorders Begins to Increase Before Diagnosis of IBD .jpeg)
Breathing Interventions May Curb Cravings With Substance Use 
Adult Children of Divorced, Unmarried Parents Face More Mental Health Issues 
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death 
Food-Based Support Aids Type 2 Diabetes Outcomes 
Hypoglossal Nerve Stimulation May Offer Long-Term Cardiovascular Benefits in OSA 
Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis Monthly Specialist Briefings
Stay Connected
